受强制性开放获取政策约束的文章 - Qingxiang Nick Lin了解详情
无法在其他位置公开访问的文章：2 篇
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
L Zhang, Y Huang, S Hong, Y Yang, G Yu, J Jia, P Peng, X Wu, Q Lin, X Xi, ...
The Lancet 388 (10054), 1883-1892, 2016
强制性开放获取政策： 国家自然科学基金委员会
Highly reproducible quantitative proteomics analysis of pancreatic cancer cells reveals proteome-level effects of a novel combination drug therapy that induces cancer cell …
S Rasam, Q Lin, S Shen, RM Straubinger, J Qu
Journal of Proteome Research 22 (12), 3780-3792, 2023
强制性开放获取政策： US Department of Defense, US National Institutes of Health
可在其他位置公开访问的文章：13 篇
LRRC25 inhibits type I IFN signaling by targeting ISG15‐associated RIG‐I for autophagic degradation
Y Du, T Duan, Y Feng, Q Liu, M Lin, J Cui, RF Wang
The EMBO journal 37 (3), 351-366, 2018
强制性开放获取政策： US National Institutes of Health, 国家自然科学基金委员会
circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis
C Hu, R Xia, X Zhang, T Li, Y Ye, G Li, R He, Z Li, Q Lin, S Zheng, R Chen
Molecular cancer 21 (1), 24, 2022
强制性开放获取政策： 国家自然科学基金委员会
An IonStar experimental strategy for MS1 ion current-based quantification using ultrahigh-field orbitrap: reproducible, in-depth, and accurate protein measurement in large cohorts
X Shen, S Shen, J Li, Q Hu, L Nie, C Tu, X Wang, B Orsburn, J Wang, J Qu
Journal of proteome research 16 (7), 2445-2456, 2017
强制性开放获取政策： US National Institutes of Health
Targeting pyruvate carboxylase by a small molecule suppresses breast cancer progression
Q Lin, Y He, X Wang, Y Zhang, M Hu, W Guo, Y He, T Zhang, L Lai, Z Sun, ...
Advanced Science 7 (9), 1903483, 2020
强制性开放获取政策： 国家自然科学基金委员会
PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis
S Liu, L Lai, Q Zuo, F Dai, L Wu, Y Wang, Q Zhou, J Liu, J Liu, L Li, Q Lin, ...
Journal of molecular and cellular cardiology 72, 28-38, 2014
强制性开放获取政策： US National Institutes of Health, 国家自然科学基金委员会
Knockdown lncRNA DLEU1 inhibits gliomas progression and promotes temozolomide chemosensitivity by regulating autophagy
QL Lv, LC Wang, DC Li, QX Lin, XL Shen, HY Liu, M Li, YL Ji, CZ Qin, ...
Frontiers in Pharmacology 11, 560543, 2020
强制性开放获取政策： 国家自然科学基金委员会
Design and optimization of hybrid of 2, 4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents
W Zhou, A Huang, Y Zhang, Q Lin, W Guo, Z You, Z Yi, M Liu, Y Chen
European Journal of Medicinal Chemistry 96, 269-280, 2015
强制性开放获取政策： 国家自然科学基金委员会
Polydatin suppresses ultraviolet B‐induced cyclooxygenase‐2 expression in vitro and in vivo via reduced production of reactive oxygen species
YD He, YT Liu, QX Lin, J Zhu, Y Zhang, LY Wang, XL Ren, XY Ye
British Journal of Dermatology 167 (4), 941-944, 2012
强制性开放获取政策： German Research Foundation
LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia
X Wang, Q Lin, F Lv, N Liu, Y Xu, M Liu, Y Chen, Z Yi
Leukemia 30 (7), 1465-1474, 2016
强制性开放获取政策： 中国科学院, 国家自然科学基金委员会
Comparative proteomic analysis identifies key metabolic regulators of gemcitabine resistance in pancreatic cancer
Q Lin, S Shen, Z Qian, SS Rasam, A Serratore, WJ Jusko, ES Kandel, ...
Molecular & Cellular Proteomics 21 (10), 2022
强制性开放获取政策： US National Institutes of Health
Synergistic pharmacodynamic effects of gemcitabine and fibroblast growth factor receptor inhibitors on pancreatic cancer cell cycle kinetics and proliferation
Q Lin, Z Qian, WJ Jusko, DE Mager, WW Ma, RM Straubinger
Journal of Pharmacology and Experimental Therapeutics 377 (3), 370-384, 2021
强制性开放获取政策： US National Institutes of Health
Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors
T Roy Chaudhuri, Q Lin, EK Stachowiak, SR Rosario, JA Spernyak, ...
Clinical Cancer Research 30 (7), 1367-1381, 2024
强制性开放获取政策： Science Foundation Ireland, Cancer Research UK, UK Medical Research Council
FGFR1 expression correlates inversely with the efficacy of single-agent FGFR-specific inhibitors in pancreatic cancer
Q Lin, A Serratore, J Perri, TR Chaudhuri, J Qu, WW Ma, RM Straubinger
Br. J. Pharmacol 10, 2023
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定